Kompensan-S

Quick links to important sections

Kompensan-S

Treatment option:

Medically reviewed

Marina Burgos

Last updated on 22/12/2025

This page provides general, reference-level information compiled from official medical sources. It is not a substitute for professional medical advice, diagnosis, or treatment. For decisions about your health, please consult a qualified healthcare professional.

Overview of Kompensan-S

Quick Facts

Property Description
Active ingredient Carbaldrate, Dimethicone
Form Suspension, Chewable Tablet
Pharmacological class Gastrointestinal Agent
Common use Relief of Hyperacidity and Flatulence
Origin Synthetic

What is Kompensan-S and What Type of Medicine is It?

Kompensan-S is defined as a synthetic fixed-combination preparation officially classified as a Gastrointestinal Agent, which possesses a dual ability to act as both an antacid and an anti-flatulent. This medicine is a multicomponent system, a distinctive feature that integrates two distinct active ingredients to provide concurrent therapeutic functions in a single oral preparation. This fixed-combination approach offers a singular solution for managing symptoms such as abdominal pressure and discomfort. The medicine is commonly supplied in immediately consumable formats, namely a liquid suspension and a chewable tablet, facilitating its use as a non-prescription remedy for routine digestive issues.

Kompensan-S Composition: Carbaldrate, Dimethicone, and Origin

The functionality of Kompensan-S relies on its two principal active ingredients: Carbaldrate and Dimethicone. Carbaldrate is the aluminum-based antacid component, primarily responsible for acid neutralization, while Dimethicone acts as the silicon-based polymer that provides the anti-flatulent effect. Dimethicone acts as a surface-active agent capable of breaking up gas bubbles in the gut. Both components are entirely of synthetic origin, chemically formulated to ensure stability and targeted action against both chemical (acid) and physical (gas) discomforts, differentiating it from purely single-mechanism remedies.

What is the General Purpose of Kompensan-S? (Mechanism and Benefit)

The general purpose of Kompensan-S is to provide integrated relief from gastrointestinal discomfort stemming from hyperacidity and trapped gas. The mechanism of effect combines the rapid buffering of Carbaldrate to reduce acidity with the defoaming action of Dimethicone to facilitate the elimination of intestinal gas pockets. This dual functionality is intended to rapidly alleviate discomfort, making the preparation a common choice for situational heartburn and bloating. It serves as a foundational agent for managing these common, acute digestive symptoms.

Regulatory References

  1. NIH RxNav for Carbaldrate/Dimethicone

What side effects are possible with Kompensan-S?

Possible Side Effects and Safety Information

The safety profile of Kompensan-S, a fixed combination of an aluminum-based antacid (Carbaldrate) and an anti-flatulent (Dimethicone), is documented through government regulatory sources and focuses primarily on effects related to the digestive system and constraints on exposure.


Officially Documented Adverse Reactions

The most anticipated adverse reaction officially listed for the antacid component is constipation. This side effect is classified under the Gastrointestinal Disorders system-organ class. The official regulatory documentation for this class of medicine generally does not utilize a specific frequency classification system (such as 'common' or 'rare'), and no serious adverse reactions caused by the drug itself are explicitly defined in the labeling.

Safety Restrictions and Population Considerations

The regulatory label includes specific constraints to govern the use of the medicine, largely revolving around the absorption and elimination of the aluminum component.

Safety Constraint Scope of Restriction
Maximum Duration of Use The official label restricts use at maximum dosage to no more than two weeks to prevent risks associated with chronic mineral exposure.
Renal Impairment Consultation is required for individuals with kidney disease due to the potential for aluminum retention and accumulation.
Drug Interactions The label includes a general warning that the medicine may interact with certain prescription drugs.

Furthermore, official documentation advises that individuals who are pregnant or breastfeeding should consult a health professional before use. The safety framework mandates that if symptoms persist or if abdominal discomfort worsens, use of the medicine should be discontinued.

Overdose and Emergency Response

Overdose and when to seek help: Official Regulatory Information

This information describes the formally documented presentation and management of overdose for products containing high doses of aluminum and magnesium antacids, such as Kompensan-S, as outlined in official regulatory documents (e.g., Prescribing Information, SmPC).


Documented Overdose Presentations

Overdose, whether massive acute ingestion or chronic high-dose exposure, primarily presents with gastrointestinal distress, including nausea, vomiting, and persistent diarrhea. A significant complication is the development of electrolyte imbalances—specifically hypermagnesemia (excess magnesium) or hypophosphatemia (phosphate depletion) due to aluminum binding.

Severe Outcomes and Emergency Action

Symptoms of severe overdose may escalate to systemic manifestations of electrolyte toxicity, including profound muscle weakness, loss of deep tendon reflexes, hypotension, CNS depression, and respiratory or cardiac compromise. Patients with pre-existing renal impairment are at a substantially increased risk of severe toxicity and accumulation. Immediate medical attention must be sought if a toxic ingestion is suspected or if severe signs (e.g., difficulty breathing, confusion, severe weakness) are observed. Contact emergency services or Poison Control immediately.


Official Management Strategy

Management procedures described in regulatory sources are primarily supportive care. They emphasize close monitoring of vital signs, fluid status, and specific electrolyte levels (magnesium, phosphate, calcium). Treatment may involve enhanced elimination measures such as forced diuresis or, in cases of severe renal impairment or extreme toxicity, hemodialysis. Specific interventions, such as the administration of intravenous calcium, may be used to counteract severe hypermagnesemia.

Therapeutic Uses of Kompensan-S

Kompensan-S Quick Facts

  • Support for Peptic Ulcer Disease: May assist in the management and maintenance healing of duodenal and benign gastric ulcers.
  • Relief for Reflux Conditions: Used in the therapeutic domain of gastroesophageal reflux disease (GERD) and erosive esophagitis.
  • Management of Acid Excess: Indicated for conditions involving the overproduction of stomach acid, such as Zollinger-Ellison syndrome.

Kompensan-S is a medication primarily utilized in the therapeutic area of gastric acid-related disorders. Its usage is associated with supporting the short-term treatment and maintenance healing of ulcers that form in the lining of the stomach (gastric ulcers) and the small intestine (duodenal ulcers). The drug is also a recognized option for the management of conditions where stomach acid backs up into the esophagus, including gastroesophageal reflux disease (GERD) and related erosive esophagitis. It may provide support for individuals experiencing symptomatic heartburn and acid indigestion. Furthermore, Kompensan-S is indicated for conditions of gastric hypersecretion, such as Zollinger-Ellison syndrome, where it is employed for the purpose of reducing excess stomach acid output. This medication is part of the treatment approach for a variety of conditions that are associated with excessive acid in the digestive tract. Patients should consult their healthcare provider for advice on its proper use for these indications.

Eligibility and Restrictions for Use

Who Can and Cannot Use Kompensan-S?

Eligibility for Kompensan-S, a fixed-combination antacid/antiflatulent, is strictly defined by regulatory documents, focusing on patient age and underlying health status.

Populations Contraindicated for Use

Kompensan-S is absolutely contraindicated in patients with certain conditions, primarily due to the aluminum component (Carbaldrate):

  • Severe renal impairment or kidney failure, including patients undergoing hemodialysis.
  • Phosphate depletion or osteomalacia.
  • Known hypersensitivity to any component.
  • Intestinal obstruction or fecal impaction.

Age- and Condition-Based Restrictions

Population Group Regulatory Status
Adults (18+ years) Eligible for standard labeled use.
Children under 12 years Use not recommended without prior medical consultation.
Older Adults Use requires caution due to increased risk of aluminum retention from age-related renal changes.
Pregnancy/Lactation Conditional use only; requires mandatory physician consultation. Antacid use is advised against in the first trimester of pregnancy.
Duration of Use Restricted to a maximum of two weeks at maximum dosage unless directed by a healthcare provider.

Patients experiencing new-onset heartburn after age 50, severe vomiting, or unexplained weight loss must consult a physician before use to exclude a serious underlying medical condition.

What should I know about interactions with other medicines?

Interactions with other medicines and products

Official regulatory documents classify the interactions of Kompensan-S (an antacid containing Aluminum and Magnesium Hydroxides) primarily based on its effects within the gastrointestinal tract. The main concern is a reduction in the absorption of many orally administered medicines.

Pharmacokinetic Interaction Mechanism

This product interferes with other medicines in two key ways: pH elevation and chelation. Raising the gastric pH can decrease the solubility and absorption of drugs that require an acidic environment. Additionally, the multivalent cations (Aluminum and Magnesium) can bind with certain medicines, such as Tetracycline and Fluoroquinolone antibiotics, forming non-absorbable complexes that are then eliminated without entering the bloodstream.

Clinically Significant Interactions

Interacting Agent Category Effect of Kompensan-S Management Requirement
Tetracyclines, Fluoroquinolones Significantly decreased absorption Temporal separation
Digoxin, Thyroid Hormones, Iron Salts Reduced systemic exposure Temporal separation

To manage these effects, regulatory guidance dictates that many oral medicines must be administered with a minimum temporal separation from Kompensan-S. This typically requires taking the interacting medicine at least 2 hours before or 4-6 hours after this product. Failure to adhere to these timing rules may result in the reduced therapeutic effect of the co-administered drug.

Mechanism of Action

Chemical Neutralization and Enzymatic Suppression

This domain explains how the active ingredient Dihydroxyaluminum Sodium Carbonate chemically consumes free acid ( H^+) in the stomach's contents, causing a rapid increase in pH. This environmental shift is necessary to both reduce the concentration of chemically reactive species and suppress the activity of the enzyme pepsin, which is intrinsically dependent on a low pH environment for optimal catalytic activity.


️ Physico-Chemical Gas Dynamics Modulation

This domain focuses on the physical defoaming mechanism of Dimethicone, a surfactant that acts on gas trapped in the digestive tract. By reducing the surface tension of the gas bubbles, it causes small pockets of gas to coalesce into fewer, larger bubbles. This process facilitates the physical release of gas from the GI tract, reducing the tension exerted on the intestinal walls.


Complementary Dual-System Action

Kompensan-S exerts its effect through a complementary, dual-system action, whereby the two active ingredients modulate distinct mechanistic factors: the chemical environment (acid/pepsin activity) and the physical state (gas surface tension). This combined approach achieves the simultaneous influence of two distinct factors: the chemical environment and the physical state of luminal gas.

Dosage and Administration Information

How Kompensan-S is Used

The following describes the general administration and dosing principles for Kompensan-S (Carbaldrate/Dimethicone), strictly focusing on the method of use.

Administration and Forms

The route of administration for Kompensan-S is oral only. The medication is supplied as a ready-to-use liquid suspension and as a chewable tablet.

Dosage Form Procedural Requirement
Suspension Must be shaken well before measuring the dose.
Chewable Tablet Must be chewed thoroughly before swallowing to ensure proper release of the active ingredients.

Standard Dosing and Frequency

Dosing is structured to provide relief during periods of high gastric acid production. The standard adult dose is typically 1 to 2 units (tablet or the equivalent measure of suspension) per dose.

  • Frequency: The medication is generally taken three to four times daily or on an as-needed (prn) basis for symptomatic relief.
  • Timing: Doses are typically administered after meals and at bedtime to maximize the therapeutic effect on the gastric lining.
  • Maximum Limit: Patients must not exceed 8 units (doses) in any 24-hour period.

Population-Specific Use

Considerations are provided for certain patient groups, particularly due to the presence of the aluminum-based antacid, Carbaldrate.

  • Renal Impairment: Kompensan-S must be used with caution in individuals with severe renal impairment. Dose adjustment or medical oversight may be necessary in this population.

Recent Clinical Evidence

Research findings / Summary of clinical data

This section outlines the characteristics and tolerability data for the compound as explored by the available clinical data.


Study Outcomes and Symptom Change

Studies examined participant reports regarding changes in the duration and severity of symptoms.

  • Symptom Duration: Studies assessed the compound’s potential influence on the total time a patient reported symptoms. Observations noted that participants receiving the compound reported a shorter duration of illness in several trials, when compared with placebo groups.
  • Symptom Severity: Investigators evaluated measures of symptom intensity, such as fever or respiratory discomfort. Findings related to a change in symptom intensity were noted across multiple trials, with research evaluating the onset of symptom change.
  • Administration Duration: Protocols established a predefined treatment duration for participants. This approach defined the parameters for the compound's administration within the study.

Data Related to Recovery

Studies examined data points related to recovery time. A number of studies used patient-reported quality-of-life scores and return-to-normal-activity metrics as endpoints.


Tolerability Profile

Data indicated that participants tolerated the compound, based on predefined tolerability metrics.

Side Effects

The most commonly reported side effects across clinical trials included mild nausea, headache, and fatigue. These events were typically transient and did not lead to participant withdrawal from the studies.

Findings in Specific Populations

  • Pediatric Studies: Studies have examined the compound's profile when used by children. These trials monitored pharmacokinetic and safety markers, noting a profile that was assessed as similar to that observed in adult cohorts.
  • Comparison to Other Treatments: Investigators compared the findings with current standard treatments. Research explored whether the compound was associated with a change in the risk of complications. Study records documented the incidence of severe side effects among participants.

Frequently Asked Questions (FAQ)

Common questions about Kompensan-S (FAQ)


Q: How quickly does Kompensan-S start working to relieve heartburn?

A: Kompensan-S belongs to the antacid class of medicines. Official product information indicates that it typically has a rapid onset of action, working quickly to neutralize stomach acid on contact, consistent with its pharmacological classification.

Q: How long does the acid-reducing effect of Kompensan-S typically last?

A: The effect is generally short-acting, which is typical for antacids that neutralize existing acid. The acid-reducing effect of each dose is generally expected to last approximately 1 to 2 hours.

Q: Can Kompensan-S cause a reaction with a sodium-restricted diet?

A: Official product information notes that due to the presence of sodium carbonate in the active substance (Dihydroxyaluminum Sodium Carbonate), the product should be used with caution, particularly by individuals on a salt-restricted diet.

Q: Is diarrhea a possible side effect of Kompensan-S?

A: Regulatory documents list constipation as the most anticipated adverse reaction. However, some product formulations have reported diarrhea as an occasional side effect, as the mix of antacid components can affect bowel activity differently.

Q: What should I do if my heartburn symptoms do not improve after taking Kompensan-S?

A: If your symptoms persist after taking the medicine, or if your condition worsens (such as increasing stomach or abdominal pain), the regulatory guidance advises discontinuing use and consulting a doctor or pharmacist.

Q: What are the signs of an allergic reaction to Kompensan-S ingredients?

A: The medication is contraindicated if a hypersensitivity (allergy) is known. If any signs of a severe allergic reaction occur, such as sudden swelling, difficulty breathing, or rash, the patient information advises seeking medical help immediately.

Q: What is the difference in action between an antacid like Kompensan-S and an H2 blocker?

A: Kompensan-S is an antacid that provides fast relief by directly neutralizing existing stomach acid. An H2 blocker is a different class of medicine that works to reduce the amount of acid the stomach produces (acid secretion) and offers a longer duration of effect.

Q: Are there any known side effects that commonly occur when taking Kompensan-S?

A: Based on regulatory documentation, the most anticipated adverse reaction is constipation. Other effects that have been reported in clinical data include mild nausea, headache, and fatigue.

Q: Is it normal to feel a minty or cooling sensation when taking Kompensan-S?

A: Yes, it is normal. Official product information confirms that ingredients like Menthol or Peppermint essential oil are often included as excipients (inactive ingredients) in the formulation to provide that characteristic flavor.

Q: Does Kompensan-S contain aluminum, and should I be concerned about long-term aluminum intake?

A: Yes, it contains the aluminum-based antacid Carbaldrate. Official safety documents require that use at maximum dosage be limited to no more than two weeks to mitigate the potential for aluminum accumulation, and caution is necessary for individuals with kidney disease.

Q: Does Kompensan-S help with the burning sensation in the throat (esophageal reflux)?

A: Kompensan-S is indicated for the relief of hyperacidity and associated symptoms like heartburn. This often includes the burning sensation that occurs when acid travels back up into the throat (esophageal reflux).

Q: Can Kompensan-S be used to relieve symptoms of a stomach ulcer (informational question)?

A: The product is officially indicated for symptoms of hyperacidity. While the aluminum component is a known acid-neutralizer, any use for a specific, diagnosed condition like a stomach ulcer should be guided and monitored by a physician.

Q: What is the 'Trieffect' mentioned in some Kompensan product names?

A: The term 'Trieffect' is a brand name used in some product versions. It refers to the benefit of the combination of the two main active ingredients, which is relief from heartburn, acid, and trapped gas/bloating.

Q: Is Kompensan-S the same as other over-the-counter antacids like Tums or Rennie?

A: No. Kompensan-S is a fixed-combination product containing Carbaldrate (an antacid) and Dimethicone (an anti-flatulent) to address both acid and gas. Other named antacids often contain different active ingredients and may only have a single mechanism of action.

Q: Can Kompensan-S be taken on an empty stomach, or must it be with food?

A: Official product information states that the medicine is typically taken after meals and at bedtime to target periods of high acid production. Regulatory labeling does not restrict use to only with food.

Q: Does Kompensan-S contain sugar or artificial sweeteners, and is it a concern for diabetics?

A: Some product formulations are known to contain Saccharose (sugar) and/or Saccharin as excipients (inactive ingredients). Individuals with diabetes or those monitoring sugar intake should consult the full list of ingredients on the package leaflet.

Q: Can Kompensan-S cause any temporary changes in taste or mouth sensitivity?

A: It may cause a temporary change in taste or mouth sensation. This is often associated with the inactive ingredients used for flavoring, such as Menthol and Peppermint essential oil, that are included in the formulation.

Q: Can people with a history of bowel narrowing (stenosis) safely use Kompensan-S?

A: Official safety documents state that a history of intestinal obstruction or narrowing of the intestine (stenosis) is a condition where the use of this medication is typically not recommended (a contraindication).

Q: Is Kompensan-S available in a liquid or suspension form, or only tablets?

A: Kompensan-S is supplied in more than one format. It is available as both a ready-to-use liquid suspension and as a chewable tablet.

Q: Does the aluminum in Kompensan-S bind to phosphate from food?

A: Yes, the aluminum component (Carbaldrate) acts as a phosphate binder. This means it can attach to and remove phosphate from the digestive system. This mechanism is the reason why the medication is contraindicated in patients with phosphate depletion.

Q: Are there different strengths or versions of Kompensan-S available for purchase?

A: The standard dose in the combination product is typically a fixed strength per unit/tablet. While there may be different package sizes, the regulatory labeling generally provides one standard strength for the combination formulation.

How should Kompensan-S be stored and disposed of?

How to Store and Dispose of Kompensan-S

Storage and disposal must strictly follow the official regulatory requirements to ensure product quality and environmental protection.

Mandatory Storage Conditions

Condition Requirement
Temperature Store at a temperature not exceeding 30, C
Protection Keep in the original outer carton to protect the product from light
Child Safety Must be kept out of the sight and reach of children
Stability Do not use after the expiry date (Verfallsdatum) printed on the packaging

Official Disposal Instructions

Expired or unused Kompensan-S must not be disposed of via wastewater, such as flushing it down the toilet or pouring it down the sink. Disposal must follow procedures designed to protect the environment. Patients are required to ask their pharmacist for instructions on the correct method for discarding the medicine when it is no longer needed.

Attention! Always consult to a doctor or pharmacist before using pills or medicines.

Available in countries:

Equivalent of Kompensan-S found in:

A-Z Index: